Inhibition of Tumor Growth and Angiogenesis by KJ3, Betulinic Acid, and Fumagillin in Mouse Neuroblastoma.
- Author:
Seung Hoon CHOI
1
;
Jung Hee LEE
;
Eui Ho HWANG
Author Information
1. Division of Pediatric Surgery, Yonsei University College of Medicine ,Seoul, Korea.
- Publication Type:Original Article
- Keywords:
KJ3;
Betulinic acid;
Fumagillin;
Antiangiogenesis;
Neuroblastoma
- MeSH:
Agar;
Angiogenesis Inhibitors;
Animals;
Cell Line;
Humans;
Lethal Dose 50;
Male;
Mice*;
Neuroblastoma*;
Thymidine Phosphorylase;
Tumor Burden
- From:Journal of the Korean Association of Pediatric Surgeons
2002;8(2):101-106
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The antiangiogenic effects of novel agent KJ3, Betulinic acid, and Fumagillin on the neovascularization were studied by examining ultrastructural alterations in the vasculature of synthetic gelform and mouse neuroblastoma C1300. Small pieces of gelform with 0.4 % agar were introduced subcutaneously (s.c.) in 7 week old male CH3/HeJ mice. After the LD50s were determined by FACS analysis, a third of LD50 of three drugs were injected either locally or intraperitoneally every other day for 14 days. A/J mice were inoculated s.c. with the C1300 neuroblastoma cell line, then either saline or three drugs were injected in the same manner. The antiangiogenic effects of three drugs were studied by measuring the histologic changes in tumors, and immunostaining for CD34, VIII/vWF, CD105, and thymidine phosphorylase. In the drug treated groups, the number of vessels in gelform experiments and C1300 neuroblastoma experiments were lower than the corresponding values in the control. The histologic findings were significantly different in drug treated groups on day 7, but these were not significant on day 14. These results imply that antiangiogenic agents were effective when the tumor burden is minimal.
